Menu
/REGISTER
Rabobank
House 2
House
Loading...
You are here:  Home  >  Health Care

Santa Barbara Web Design
Latest

Genentech sues Amgen over biosimilar drug info

By   /  Monday, February 20th, 2017  /  Health Care, Latest news, Technology  /  No Comments

Roch AG subsidiary Genentech filed a lawsuit against Amgen claiming the Thousand Oaks-based company obstructed its investigation of whether the biosimilar Amgen is developing for Genentech’s cancer treatment Avastin violates the company’s patents, according to reports Feb. 20. Sales for Avastin, a treatment for lung, colon, ovarian and other types of cancer, reached $6.8 billion Read More →

Read More →
Latest

Amgen applies for FDA approval of Blincyto

By   /  Tuesday, February 14th, 2017  /  Health Care, Latest news, Technology  /  No Comments

Thousand Oaks-based Amgen submitted an application for Blincyto to the U.S. Food and Drug Administration, the company announced on Feb. 14. Amgen aims to gain approval for Blincyto to treat Philadelphia chromosome-positive relapsed or refractory B-cell precursor acute lymphoblastic leukemia. The drug was previously granted breakthrough therapy designation and accelerated approval in December 2014. “Acute Read More →

Read More →
Latest

Drug sales for biotech giant Amgen boost bottom line

By   /  Friday, February 10th, 2017  /  Earnings, Health Care, left, Technology, Tri-County Public Companies  /  No Comments

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Atara Biotherapeutics moving research division to Thousand Oaks

By   /  Wednesday, February 8th, 2017  /  Health Care, Latest news, Technology  /  No Comments

Atara Biotherapeutics will move its research and development division from Westlake Village to Thousand Oaks, the company said in a news release. The company plans to occupy 91,000 square feet at the yet-to-be-constructed Conejo Spectrum Business Park off of Lawrence Drive and Conejo Spectrum Street. The Sares-Regis Group bought 29 acres of land at the Read More →

Read More →
Latest

FDA approves Amgen’s Parsabiv drug to treat chronic kidney disease

By   /  Tuesday, February 7th, 2017  /  Health Care, Latest news  /  No Comments

The U.S. Food and Drug Administration approved Amgen’s Parsabiv drug to treat patients with chronic kidney disease, the company announced on Feb. 7. The Thousand Oaks-based biotech company’s Parsabiv is the first therapy approved for the treatment of secondary hyperparathyroidism for patients on hemodialysis in 12 years, Amgen said. “We are excited about today’s approval Read More →

Read More →
Latest

Amgen funds STEM program for Girl Scouts

By   /  Friday, February 3rd, 2017  /  Education, Health Care, Latest news, Nonprofits  /  No Comments

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen beats analyst estimates for fourth quarter revenue

By   /  Thursday, February 2nd, 2017  /  Earnings, Health Care, Latest news, Technology, Tri-County Public Companies  /  No Comments

Thousand Oaks-based biotech giant Amgen reported revenue of $6 billion in the fourth quarter of 2016, besting analyst estimates of $5.74 billion and increasing 8 percent from the fourth quarter of 2015. The world’s largest biotech drug maker posted total revenues of $23 billion on the year, up 6 percent from 2015. Revenue gains were Read More →

Read More →